Role of platelet factor 3 in the hypercoagulability induced by pregnancy and oral contraceptives.
D000328:Adult; D000818:Animals; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D006801:Humans; D008656:Mestranol / Q000009:adverse effects; D008722:Methods; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects; D009644:Norgestrel / Q000009:adverse effects; D010714:Phosphatidylethanolamines; D010973:Platelet Adhesiveness / Q000187:drug effects; D011247:Pregnancy; D011517:Prothrombin Time; D051381:Rats; D013925:Thromboplastin / Q000502:physiology*
D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D010714:Phosphatidylethanolamines; D009644:Norgestrel; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D013925:Thromboplastin; D008656:Mestranol; D009640:Norethindrone